In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Procept BioRobotics Corp (NASDAQ: PRCT) closed the day trading at $80.78 down -1.66% from the previous closing price of $82.14. In other words, the price has decreased by -$1.66 from its previous closing price. On the day, 1.09 million shares were traded. PRCT stock price reached its highest trading level at $83.78 during the session, while it also had its lowest trading level at $79.3.
Ratios:
For a better understanding of PRCT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.07 and its Current Ratio is at 6.02. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on December 02, 2024, initiated with a Overweight rating and assigned the stock a target price of $105.
On November 14, 2024, Jefferies started tracking the stock assigning a Hold rating and target price of $95.
On August 11, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $42.Piper Sandler initiated its Overweight rating on August 11, 2023, with a $42 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 04 ’24 when Zadno Reza sold 26,423 shares for $97.22 per share. The transaction valued at 2,568,844 led to the insider holds 152,762 shares of the business.
Nouri Alaleh sold 28,092 shares of PRCT for $2,728,574 on Dec 04 ’24. The EVP, CLO, CORP. SEC. now owns 52,472 shares after completing the transaction at $97.13 per share. On Dec 04 ’24, another insider, REZA ZADNO, who serves as the Director of the company, bought 26,423 shares for $96.48 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRCT now has a Market Capitalization of 4370706944 and an Enterprise Value of 4101233664. For the stock, the TTM Price-to-Sale (P/S) ratio is 21.99 while its Price-to-Book (P/B) ratio in mrq is 17.46. Its current Enterprise Value per Revenue stands at 20.522 whereas that against EBITDA is -40.461.
Stock Price History:
Over the past 52 weeks, PRCT has reached a high of $103.81, while it has fallen to a 52-week low of $39.48. The 50-Day Moving Average of the stock is -7.74%, while the 200-Day Moving Average is calculated to be 15.69%.
Shares Statistics:
Over the past 3-months, PRCT traded about 808.73K shares per day on average, while over the past 10 days, PRCT traded about 510950 shares per day. A total of 52.15M shares are outstanding, with a floating share count of 51.55M. Insiders hold about 5.23% of the company’s shares, while institutions hold 84.22% stake in the company. Shares short for PRCT as of 1732838400 were 6090551 with a Short Ratio of 7.53, compared to 1730332800 on 5896747. Therefore, it implies a Short% of Shares Outstanding of 6090551 and a Short% of Float of 15.22.
